Snowden Capital Advisors LLC Axonics, Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jan 08, 2024
SELL
$16.44 - $37.73 $657,600 - $1.51 Million
-40,000 Closed
0 $0
Q4 2019

Jan 08, 2024
BUY
$19.57 - $28.96 $782,800 - $1.16 Million
40,000 New
40,000 $11.1 Million
Q3 2019

Jan 08, 2024
SELL
$26.92 - $42.41 $403,800 - $636,150
-15,000 Closed
0 $0
Q2 2019

Jan 08, 2024
BUY
$18.54 - $40.97 $278,100 - $614,550
15,000 New
15,000 $18.4 Million

Others Institutions Holding AXNX

# of Institutions
235
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email